Paying for WAINUA

What can I expect to pay for WAINUA?

Most patients do not pay the list price for WAINUA. Your actual cost will vary based on your insurance coverage.*

The list price for WAINUA is $42,830.83 per 45 mg. For adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis, the recommended dose of WAINUA is 45 mg administered by subcutaneous injection once monthly.

Talk to your insurance provider.
The information below may help you estimate your cost for WAINUA based on your insurance, but your insurance provider can provide more specific information.

Select your insurance type for more information:

With the WAINUA Savings Program, eligible, commercially insured patients may be able to pay as little as $0 per month for WAINUA.

Subject to eligibility rules; restrictions apply. Patients must be enrolled in the WAINUA Savings Program.

To be eligible for the WAINUA Savings Program, you must:

  • Have commercial insurance
  • Have a valid prescription for WAINUA
  • Have WAINUA approved by your insurance plan
  • Be a resident of the United States or Puerto Rico
  • Be enrolled in the WAINUA Savings Program
Enroll in the WAINUA Savings Program

AstraZeneca Access 360™ can help you learn which programs you may be eligible for. You could be eligible for support even if you don’t have insurance coverage or have been denied insurance coverage.

Reach out to Access 360 at 1-844-2-WAINUA (1-844-292-4682) and ask about the options that may be available to you.

*Your actual cost, also called “out-of-pocket cost,” refers to all expenses that are not covered by your insurance.

AnalySource/First Data Bank as of May 2025.

Our commitment to access and affordability

AstraZeneca and Ionis believe it’s not enough for us to simply make medicines. We have to help ensure that the people who need our medicines have access to them. In fact, we’ve been offering financial support programs for more than 40 years, and we provide other resources and services to help people access the medicines they need.

Important Safety Information

WAINUA may cause side effects, including:

Low vitamin A level, which is a serious, but common side effect of treatment with WAINUA. Your doctor should tell you to take vitamin A supplements. Do not take more than the amount of vitamin A your doctor has recommended. Call your doctor if you develop eye problems such as difficulty seeing at night or in low-lit areas (night blindness), or dry eyes. If you develop eye problems, your doctor should refer you to an eye doctor

APPROVED USES

WAINUA injection, for subcutaneous use, 45 mg is a prescription medicine used to treat adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis.

The most common side effects include decreased vitamin A and vomiting.

Before you take WAINUA, tell your healthcare provider:

  • if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if WAINUA can harm your baby. Changes in vitamin A levels and vitamin A supplementation related to use of WAINUA may harm your unborn baby. It is not known if WAINUA passes into breast milk
  • about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take vitamin A or beta-carotene supplements

APPROVED USES

WAINUA injection, for subcutaneous use, 45 mg is a prescription medicine used to treat adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis.

Please see full Prescribing Information, including Patient Information.

You may report side effects related to AstraZeneca products .

Important Safety Information

+